WASHINGTON, D.C.—Global Liver Institute (GLI) will convene the fourth International NASH Day on June 10, 2021. Eight virtual panels of international experts will shed light on nonalcoholic steatohepatitis (NASH), the advanced form of nonalcoholic fatty liver disease (NAFLD), and the actions people can take to address this life-threatening disease worldwide.
This year’s theme is NASH Around the World. The COVID-19 pandemic exacerbated the conditions that accompany NASH, with quarantine-imposed sedentary lifestyles, the disruption of school-provided meals for children, and the loss of the income to buy healthful food all increasing risks for obesity and diabetes. NASH awareness is more important than ever, as many countries emerge from the pandemic, with individuals resuming routine medical care, dining out, and exercise routines. “The time has never been better for NASH education, prevention, and screening,” said Donna Cryer, GLI president and CEO.
International NASH Day has taken place every June since 2018. International NASH Day 2020 featured 80 partner organizations in 26 countries and 25 international speakers on six virtual panels. International NASH Day 2021 is expected to have an even bigger reach. The event draws more participants and viewers each year, as awareness of the event and NASH grows worldwide.
International NASH Day 2021 will be broadcast in English, Spanish, French, Mandarin, and Hindi.
What: International NASH Day 2021
When: Thursday, June 10, 2021
How to watch: Register here.
Join the conversation and use #NASHDay across all social media platforms.
About Global Liver Institute
Global Liver Institute (GLI) is the only patient-driven liver health advocacy organization operating in the United States and Europe. Headquartered in Washington, D.C., United States, the nonprofit GLI advances its vision for liver health to take its place on the global public health agenda commensurate with the prevalence and impact of liver disease. GLI’s mission is to improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and supporting the scaling of optimal approaches to help eradicate liver diseases. Follow us on Twitter, Facebook, Instagram, LinkedIn, and YouTube.